The National Institutes of Health failed to protect brain scans that an international group of fringe researchers used to argue for the intellectual superiority of white people. Credit...Ben Denzer ...

I thought I would leave pottery class with a new 16-piece dinnerware set. Instead, I left with eight new friends. My plan was to take a five-week series at Gather Pottery in Seattle’s Interbay ...

UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. PATH's revenue growth re-accelerated to 15.9% in Q3 FY26, with raised full-year ...

UiPath is at an inflection point, with stabilizing SaaS metrics, renewed growth, and a strong AI-driven product roadmap. PATH’s Maestro platform uniquely integrates deterministic RPA and probabilistic ...

Palantir's stock rise has been driven by its AI platform, which acts as an AI operating system. UiPath's Maestro platform, which acts as an orchestration platform for AI agents, could be a similar ...

The AI orchestration platform is seeing its revenue accelerate. However, the company is just starting to tap into its potential. Meanwhile, the stock is still cheap despite its recent surge. For those ...

UiPath Inc. (NYSE: PATH) stock jumped in Wednesday's extended trading after the company released its third quarter earnings report, beating expectations on the top and bottom lines. Here's a look at ...

There may be no enterprise job today that can’t be enhanced through the use of automation and AI, and agentic AI represents the next step toward fully realizing that potential. So says Daniel Dines, ...